ENDRA Life Sciences Inc. Warrants
NDRAW
NDRAW was delisted on the 12th of May, 2022.
2 hedge funds and large institutions have $4K invested in ENDRA Life Sciences Inc. Warrants in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
300% more capital invested
Capital invested by funds: $1K → $4K (+$3K)
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.64K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$703 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $3K | +$7.64K | +33,319 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | +$703 | +3,068 | +87% |
|
NDRAW Hedge Fund Activity: Q4 2021 in Review
2 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences Inc. Warrants (NDRAW) for Q4 2021, worth a combined $4K — up 300% from $1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NDRAW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $7.64K.
- 2 institutional investors held ENDRA Life Sciences Inc. Warrants (NDRAW) as of Q4 2021, up from 1 in Q3 2021.
- Funds reported $4K of ENDRA Life Sciences Inc. Warrants stock for Q4 2021, up 300% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences Inc. Warrants positions in Q4 2021 and 0 closed out, a net change of +1 holder.
- The largest ENDRA Life Sciences Inc. Warrants buyer in Q4 2021 was Susquehanna International Group, an estimated $7.64K added.
Based on aggregated 13F filings for Q4 2021.